Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$77.7 - $123.62 $264,180 - $420,308
-3,400 Reduced 25.37%
10,000 $1.1 Million
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $229,593 - $323,895
-3,900 Reduced 22.54%
13,400 $1.08 Million
Q1 2024

May 15, 2024

BUY
$51.07 - $68.26 $674,124 - $901,032
13,200 Added 321.95%
17,300 $1.08 Million
Q4 2023

Feb 14, 2024

SELL
$55.6 - $77.89 $8.08 Million - $11.3 Million
-145,300 Reduced 97.26%
4,100 $254,000
Q3 2023

Nov 14, 2023

BUY
$60.27 - $90.75 $7.55 Million - $11.4 Million
125,300 Added 519.92%
149,400 $10.4 Million
Q2 2023

Aug 14, 2023

SELL
$82.41 - $99.65 $238,989 - $288,985
-2,900 Reduced 10.74%
24,100 $2.02 Million
Q1 2023

May 15, 2023

SELL
$47.76 - $82.86 $157,608 - $273,438
-3,300 Reduced 10.89%
27,000 $2.23 Million
Q4 2022

Feb 14, 2023

BUY
$48.76 - $77.67 $975,200 - $1.55 Million
20,000 Added 194.17%
30,300 $1.54 Million
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $589,632 - $828,384
9,600 Added 1371.43%
10,300 $724,000
Q2 2022

Aug 08, 2022

BUY
$55.54 - $72.65 $11,108 - $14,530
200 Added 40.0%
700 $46,000
Q1 2022

May 16, 2022

SELL
$24.28 - $56.64 $48,560 - $113,280
-2,000 Reduced 80.0%
500 $28,000
Q4 2021

Feb 14, 2022

BUY
$22.54 - $30.44 $33,810 - $45,660
1,500 Added 150.0%
2,500 $72,000
Q3 2021

Nov 15, 2021

BUY
$24.23 - $28.59 $21,807 - $25,731
900 Added 900.0%
1,000 $26,000
Q2 2021

Aug 16, 2021

SELL
$19.51 - $27.64 $370,690 - $525,160
-19,000 Reduced 99.48%
100 $3,000
Q1 2021

May 17, 2021

BUY
$13.77 - $21.66 $263,007 - $413,706
19,100 New
19,100 $408,000
Q4 2020

Feb 16, 2021

SELL
$10.75 - $14.91 $33,325 - $46,221
-3,100 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$11.98 - $16.34 $37,138 - $50,654
3,100 New
3,100 $39,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.